|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expense: | |||||
| Licensing costs | |||||
| Research and development | |||||
| Selling, general and administrative expenses | |||||
| Impairment loss on investment | |||||
| Total operating expense | |||||
| (Loss) from operations | |||||
| Interest and other income, net | |||||
| (Loss) before taxes | |||||
| Income tax (provision) benefit | |||||
| Net (loss) | |||||
| Basic (loss) per share (in Dollars per share) | |||||
| Diluted (loss) per share (in Dollars per share) | |||||
| Weighted average shares outstanding basic (in Shares) | |||||
| Weighted average shares outstanding diluted (in Shares) | |||||
Loading...
